Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652247 · ClinicalTrials.gov registry record · NA
Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02652247 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 110 participants.
The verdict
NCT02652247, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
To determine if the analysis of exhaled breath condensate correlates with the development \& resolution of pneumonia.
Interventions
- PROCEDURE molecular analysis of exhaled breath condensate
- PROCEDURE molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
- PROCEDURE molecular analysis of bronchoalveolar lavage (BAL) aspirate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02652247
The ClinicalTrials.gov registry entry for NCT02652247 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which molecular analysis of exhaled breath condensate is the first listed.
NCT02652247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02652247 about?
NCT02652247 is a clinical study titled "Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients". To determine if the analysis of exhaled breath condensate correlates with the development \& resolution of pneumonia.
What is the current status of trial NCT02652247?
This trial is currently terminated. It is a NA study. The enrollment target is 110 participants. The study started on 2016-01. Estimated completion is 2022-06.
What interventions are being tested in trial NCT02652247?
The interventions under investigation include: molecular analysis of exhaled breath condensate (PROCEDURE), molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate (PROCEDURE), molecular analysis of bronchoalveolar lavage (BAL) aspirate (PROCEDURE).
Who is sponsoring clinical trial NCT02652247?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.